Systemic sclerosis (scleroderma) in two iron ore mines

Occupational Medicine

Volumn 49, Issue 3, 1999, Pages 161-169

  Martin, J R ^a   Griffin, M ^a   Moore, E ^a   Lochead, J A ^a   Edwards, A C ^a   Williams, J ^a   Khraishi, M M ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Pneumoconiosis; Pulmonary features; Scleroderma

Indexed keywords

IRON; SILICON DIOXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG PARENCHYMA; MALE; MINER; PNEUMOCONIOSIS; PRIORITY JOURNAL; SCLERODERMA;

ADULT; AGED; DUST; HUMANS; INHALATION EXPOSURE; IRON; MALE; MIDDLE AGED; MINING; OCCUPATIONAL EXPOSURE; SCLERODERMA, SYSTEMIC; SILICON DIOXIDE;

EID: 0032923514     PISSN: 09627480     EISSN: None     Source Type: Journal    
DOI: 10.1093/occmed/49.3.161     Document Type: Article

References (40)

1. Bramwell B. Diffuse scleroderma: its frequency: its occurrence in stone masons. Edin Med J 1914; 12: 387-401.
2. Erasmus LD. Scleroderma in gold miners on the Witwatersrand with particular reference to pulmonary manifestations. S Afr J Lab Clin Med 1957; 3: 209-231.
3. Rodnan GP, Benedek TG, Medsger TA Jr, Cammarata RJ. The association of progressive systemic sclerosis (scleroderma) with coal miner's pneumoconiosis and other forms of silicosis. Ann Intern Med 1967; 66: 323-334.
4. Rojo AR. Neumoconioses y colagenosis. Medicina Y Seguridad Del Trabajo 1982; 20: 308-311.
5. Sluis-Cremer GK, Hessel PA, Nizdo EH, Churchill AR, Zeiss EA. Silica, silicosis and progressive systemic sclerosis. Br J Ind Med 1985; 42: 838-843.
6. Cowie RL. Silica dust exposed mine workers with scleroderma (systemic sclerosis). Chest 1987; 92: 260-262.
7. Haustein UF, Ziegler V, Hermann K, Melhorn J, Schmidt C. Silica induced scleroderma. J Am Acad Dermatol 1990; 22: 444-448.
8. Gabay C, Kahn MF. Male type scleroderma. The role of occupational exposure. Schweiz-Med-Wochenschr 1992; 122: 1746-1752.
9. Archer C, Gordon DA. Silica and progressive systemic sclerosis (scleroderma). Evidence for workers' compensation policy. Am J Ind Med 1996; 29: 533-538.
10. Medsger TA Jr, Masi AT. The epidemiology of systemic sclerosis (scleroderma) among male US veterans. J Chronic Dis 1978; 31: 73-85.
11. Silman AJ, Jones S. What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann Rheum Dis 1992; 51: 1322-1324.
12. Masi AT, Rodnan GP, Medsger TA, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association. Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-590.
13. Moore E, Knight G. Interpretation of historic impinger data. American Industrial Hygiene Conference. Detroit, MI, USA, May 1984.
14. Moore E, Muir DCF, Martin JR, Edwards AC. A case control study to investigate the association between indices of dust exposure and the development of radiologic pneumoconiosis. Arch Environ Health 1987; 42: 351-355.
15. Flower CDR. Systemic sclerosis. In: Grainger RG, Allison DJ, eds. Diagnostic Radiology. An Anglo-American Textbook of Imaging. London, UK: Churchill Livingstone, 1986: 282-283
16. Flower CDR. Systemic sclerosis. In: Grainger RG, Allison DJ, eds. Diagnostic Radiology. An Anglo-American Textbook of Imaging. London, UK: Churchill Livingstone, 1986: 268-269.
17. Parkes WR. Occupational Lung Disorders, Second Edition. London, UK: Butterworths, 1982: 142-144.
18. Hunninghake GW, Fauci AS. Pulmonary involvement in the collagen vascular diseases. Am Rev Resp Dis 1979; 119: 471-403.
19. Rocco UK, Hund ER. Scleroderma and scleroderma-like disorders. Semin Arth Rheum 1986; 16: 22-69.
20. Alton E, Turner Warwick M. Lung Involvement in Scleroderma Systemic Sclerosis: Scleroderma. Jayson MIV and Black CM, eds. Chichester, UK:. John Wiley and Sons, 1988.
21. Griffin MT, Robb JD, Martin JR. Diffuse alveolar haemorrhage associated with progressive systemic sclerosis. Thorax 1990; 45: 903-904.
22. Mark EJ, Ramirez JF. Pulmonary capillaritis and hemorrhage in patients with systemic vasculitis. Arch Pathol Lab Med 1985; 109: 413-418.
23. Moore E, Martin JR, Edwards AC, et al. Dust exposure indices at the earliest appearance of pneumoconiosis. Proceedings of the VIIth International Pneumoconiosis Conference, Pittsburgh PA, USA, 1988. DHHS (NIOSH) Publication No. 90-108, Part 1. US Department of Health and Human Services, Public Health Service, Centres for Disease Control, National Institute for Occupational Safety and Health. 1988: 672-677.
24. Rustin MHA, Bull HA, Ziegler V, et al. Silica associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis. Br J Dermatol 1990; 123: 725-734.
25. Guenther G, Schuchardt E. Silikose und-progressive sklerodermie. Besteht Ein Atiologischer Zusammenhang. Deutsch Med Wschr 1970; 95: 467-468.
26. Freneaux B, Freneaux J, Buyse N, LeVan Quyen H. L'association silicose sclerodermie. Nouv Presse Med 1975; 4: 2087-2090.
27. Zschunke E. Occupational scleroderma in workers exposed to silica dust. In: Maiback HI, Gellin GA, eds. Occupational and Industrial Dermatology. Chicago, IL (USA): Chicago Year Book Publishers, 1982: 339-342.
28. Edstrom HW, Rice DMD. 'Labrador Lung' - An unusual mixed dust pneumoconiosis. Canad Med Assoc J 1982; 126: 27-30.
29. Silman A. Scleroderma and survival. Ann Rheum Dis 1991; 50: 267-269.
30. Abu-Shakra M, Gullemin F, Lee P. Cancer in systemic sclerosis. Arthritis Rheum 1993; 36: 460-464.
31. Black C, Dieppe P, HuskissonT, Hart FD. Regressive systemic sclerosis. Ann Rheum Dis 1986; 45: 384-388.
32. Seaton A, Dodgson J, Dick JA, Jacobsen M. Quartz and pneumoconiosis in coal miners. Lancet 1981; 2: 1272-1275.
33. Masi AT. Clinical epidemiological perspectives of systemic sclerosis (scleroderma). In: Jayson MIV, Black CM, eds. Systemic Sclerosis: Scleroderma. Chichester, UK: John Wiley and Sons, 1988.
34. Silman A. Epidemiology of scleroderma. Ann Rheum Dis 1991; 50(Suppl4): 846-851.
35. Medsger TA, Masi AT. The epidemiology of systemic sclerosis (scleroderma). Ann Int Med 1971; 74: 714-721.
36. Eason RJ, Tan PL, Gow PJ. Progressive systemic sclerosis in Auckland: A ten year review with emphasis on prognostic features. Aust NZ J Med 1981; 6: 657-662.
37. Michet CJ, McKenna CH, Elveback LR, et al. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota 1950 through 1979. Mayo Clin Proc 1985; 60: 105-113.
38. Silman A, Jannin S, Symmons D, Bacon P. An epidemiologic study of scleroderma in the West Midlands. Br J Rheumatol 1988; 27: 286-290.
39. Stone OJ. Autoimmunity is a secondary phenomenon in scleroderma and so called adjuvant disease. Med Hypoth 1991; 34: 127-130.
40. McHugh NJ, Whyte J, Harvey G, Haustein UF. Anti topo-isomerase I antibodies in silica-associated systemic sclerosis. A mode for auto immunity. Arthritis Rheum 1994; 37: 1198-1205.